BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 25111771)

  • 1. Thirty-day readmission rates after PCI in a metropolitan center in Europe: incidence and impact on prognosis.
    Moretti C; D'Ascenzo F; Omedè P; Sciuto F; Presutti DG; Di Cuia M; Colaci C; Giusto F; Ballocca F; Cerrato E; Colombo F; Gonella A; Giordana F; Longo G; Vilardi I; Bertaina M; Orlando A; Andrini R; Ferrando A; DiNicolantonio JJ; Zoccai GB; Sheiban I; Gaita F
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):238-45. PubMed ID: 25111771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in the Rate of 30-Day Readmissions after Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Lam L; Ahn HJ; Okajima K; Schoenman K; Seto TB; Shohet RV; Miyamura J; Sentell TL; Nakagawa K
    Womens Health Issues; 2019; 29(1):17-22. PubMed ID: 30482594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of short-term readmission after percutaneous coronary intervention.
    Wasfy JH; Strom JB; O'Brien C; Zai AH; Luttrell J; Kennedy KF; Spertus JA; Zelevinsky K; Normand SL; Mauri L; Yeh RW
    Circ Cardiovasc Interv; 2014 Feb; 7(1):97-103. PubMed ID: 24425587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early readmissions after percutaneous coronary intervention in a rural tertiary care center (from the Guthrie Health Off-label Stent [GHOST] Registry).
    Harjai KJ; Singh M; Boura J
    Am J Cardiol; 2012 Aug; 110(4):491-7. PubMed ID: 22579345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome.
    Lemor A; Hernandez GA; Patel N; Blumer V; Sud K; Cohen MG; De Marchena E; Kini AS; Sharma SK; Alfonso CE
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):373-379. PubMed ID: 30280472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readmission in the 30 days after percutaneous coronary intervention.
    Yost GW; Puher SL; Graham J; Scott TD; Skelding KA; Berger PB; Blankenship JC
    JACC Cardiovasc Interv; 2013 Mar; 6(3):237-44. PubMed ID: 23517834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and predictors of rehospitalisation following an acute coronary syndrome: report from the Australian and New Zealand population of the Global Registry of Acute Coronary Events (GRACE).
    Sangu PV; Ranasinghe I; Aliprandi Costa B; Devlin G; Elliot J; Lefkovitz J; Brieger D
    Heart; 2012 Dec; 98(23):1728-31. PubMed ID: 23010286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients.
    Curtis JP; Schreiner G; Wang Y; Chen J; Spertus JA; Rumsfeld JS; Brindis RG; Krumholz HM
    J Am Coll Cardiol; 2009 Sep; 54(10):903-7. PubMed ID: 19712799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).
    Kwok CS; Potts J; Gulati M; Alasnag M; Rashid M; Shoaib A; Ul Haq MA; Bagur R; Mamas MA
    Am J Cardiol; 2018 Apr; 121(7):810-817. PubMed ID: 29448978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis.
    Meadows ES; Bae JP; Zagar A; Sugihara T; Ramaswamy K; McCracken R; Heiselman D
    BMC Res Notes; 2012 Jul; 5():342. PubMed ID: 22747631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Readmission after inpatient percutaneous coronary intervention in the Medicare population from 2000 to 2012.
    McNeely C; Markwell S; Vassileva CM
    Am Heart J; 2016 Sep; 179():195-203. PubMed ID: 27595697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause readmission and repeat revascularization after percutaneous coronary intervention.
    Przybysz-Zdunek B; Ploch M; Pluta W; Dada M; Opolski G
    Cardiol J; 2012; 19(2):174-9. PubMed ID: 22461051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
    Patti G; Pasceri V; Mangiacapra F; Colonna G; Vizzi V; Ricottini E; Montinaro A; D'Ambrosio A; Wijns W; Barbato E; Di Sciascio G;
    Am J Cardiol; 2013 Jul; 112(2):162-8. PubMed ID: 23601577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of moderate-to-severe obstructive sleep apnea on the clinical manifestations of plaque vulnerability and the progression of coronary atherosclerosis in patients with acute coronary syndrome.
    Nakashima H; Kurobe M; Minami K; Furudono S; Uchida Y; Amenomori K; Nunohiro T; Takeshita S; Maemura K
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):75-84. PubMed ID: 24855286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).
    Lansky AJ; Ng VG; Meller S; Xu K; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):266-75. PubMed ID: 24650400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.